LI SUSAN J 4

4 · Meta Platforms, Inc. · Filed Mar 24, 2026

AI-generated summary of this filing

Updated Mar 25, 2026

Meta (META) CFO Susan Li Receives Awarded RSUs and Option Tranches

What Happened

Susan J. Li, Chief Financial Officer of Meta Platforms, received multiple grants on March 20, 2026 totaling 697,132 derivative awards (reported as grants/awards). Each reported grant shows an acquisition price of $0.00 (i.e., awards were granted, not purchased).
The filing lists individual tranches of 43,267; 12,806; 18,066; 29,340; 97,541; 155,491; 249,382; and 91,239 units. Some awards are Restricted Stock Units (RSUs) and others are stock-option tranches, per the filing footnotes.

Key Details

Transaction date: March 20, 2026; Form 4 filed March 24, 2026 (timely within the two-business-day reporting window).
Quantity granted: 697,132 total derivative awards (sum of the eight tranches listed).
Reported price: $0.00 for each grant (reflects grant/award status, not a cash purchase).
Shares owned after transaction: Not specified in the provided summary of the filing.
Notable footnotes:
- F1: RSUs convert to 1 share of Class A common stock upon settlement.
- F2: RSU vesting: quarterly as to 1/16th of the total RSUs beginning May 15, 2026, conditioned on continued service.
- F3–F4: Option tranches have a “Price Vesting Period” through Feb 14, 2028 — if the stock price meets/exceeds the tranche exercise price during that period, the tranche vests then (subject to service). Any tranches not vested by then have a post‑period schedule: 6/16ths vest on Feb 15, 2028, then 1/16th quarterly through Aug 15, 2030 (subject to service).
Filing timeliness: Filed on 3/24/2026 for a 3/20/2026 grant — within the normal Form 4 reporting window.

Context

These are awards/grants (not an open‑market purchase or sale). RSUs represent rights to shares upon settlement; options require meeting price and service conditions before becoming exercisable/convertible to shares. Awards like these are typical components of executive compensation and vest over time or upon performance/price triggers — they do not indicate an immediate purchase or sale of stock.

Form 4

Period: 2026-03-20

Chief Financial Officer

Transactions

Award
Restricted Stock Units (RSU) (Class A)
[F1][F2]
2026-03-20+43,267→ 43,267 total
→ Class A Common Stock (43,267 underlying)
Award
Stock Options (right to buy)
[F3][F4]
2026-03-20+12,806→ 12,806 total
Exercise: $1116.08Exp: 2031-03-19→ Class A Common Stock (12,806 underlying)
Award
Stock Options (right to buy)
[F3][F4]
2026-03-20+18,066→ 18,066 total
Exercise: $1393.87Exp: 2031-03-19→ Class A Common Stock (18,066 underlying)
Award
Stock Options (right to buy)
[F3][F4]
2026-03-20+29,340→ 29,340 total
Exercise: $1724.41Exp: 2031-03-19→ Class A Common Stock (29,340 underlying)
Award
Stock Options (right to buy)
[F3][F4]
2026-03-20+97,541→ 97,541 total
Exercise: $2114.87Exp: 2031-03-19→ Class A Common Stock (97,541 underlying)
Award
Stock Options (right to buy)
[F3][F4]
2026-03-20+155,491→ 155,491 total
Exercise: $2573.06Exp: 2031-03-19→ Class A Common Stock (155,491 underlying)
Award
Stock Options (right to buy)
[F3][F4]
2026-03-20+249,382→ 249,382 total
Exercise: $3107.44Exp: 2031-03-19→ Class A Common Stock (249,382 underlying)
Award
Stock Options (right to buy)
[F3][F4]
2026-03-20+91,239→ 91,239 total
Exercise: $3727.12Exp: 2031-03-19→ Class A Common Stock (91,239 underlying)

Footnotes (4)

[F1]Each Restricted Stock Unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement.
[F2]The RSUs vest quarterly as to 1/16th of the total RSUs, beginning on May 15, 2026, subject to continued service through each vesting date.
[F3]The stock options to acquire Issuer's Class A Common Stock (the "Options") vest and become exercisable as follows: from the date of grant up to and including February 14, 2028 (the "Price Vesting Period"), if the per share price of the Issuer's Class A Common Stock on NASDAQ meets or exceeds the per share exercise price relating to the applicable tranche of Options set forth above at any time during the Price Vesting Period, then each such tranche of Options will fully vest on such date, subject to the Reporting Person's continued service through each such date.
[F4]Following the Price Vesting Period, any tranches of Options that did not vest during the Price Vesting Period will only vest with respect to 6/16ths of the total Options on February 15, 2028, and then 1/16th of the total Options quarterly thereafter, with the final 1/16th of the total Options vesting on August 15, 2030, with the vesting occurring equally across each tranche, subject to the Reporting Person's continued service through each such date.

Signature

/s/ Erin Guldiken, attorney-in-fact for Susan J. Li|2026-03-24

1 file